-
Center for Drug Evaluation of NMPA Announced on Issuing the Administrative Measures for Communication of Drug R&D and Technical Review
2020-12-11
The Center for Drug Evaluation organized the revision of the Administrative Measures for Communication of Drug R&D and Technical Review, been released with NMPA's examination and approval for implementation as from December 10, 2020.
-
NMPA issued the Announcement on Matters Concerning the Production of Imported Medical Devices in Domestic Enterprises in China
2020-09-25
On September 18, 2020, NMPA announced the following matters concerning the production of products with imported medical device registration certificates in domestic enterprises in China.
-
NMPA and General Administration of Customs issued the Announcement on the Setting up of Wuxi Airport and Jiangyin Port as Drug Import Ports
2020-09-14
On September 2, 2020, NMPA and General Administration of Customs issued the following announcement.
-
NMPA issued the Announcement on Provisions for the Filing of Medical Representatives (Interim)
2020-09-30
NMPA has organized to formulate the Provisions for the Filing of Medical Representatives (Interim), which was issued on September 22, 2020.
-
NMPA Issues Announcement on Performing Consistency Evaluation of the Quality and Efficacy of Generic Chemical Injections
2020-05-14
NMPA released an Announcement on May 14, 2020, with decisions made to perform consistency evaluation of the quality and efficacy of generic chemical injections (hereinafter referred to as the consistency evaluation of injections), relevant issues are announced as follows.
-
NMPA Issues Guidance for On-Site Inspection of Independent Software Appended in Good Manufacturing Practice for Medical Devices
2020-06-04
NMPA organized to formulate and released on June 4, 2020 the Guidance for On-Site Inspection of Independent Software Appended in Good Manufacturing Practice for Medical Devices.